[1]
R. K. Ranjan and A. Chandra, “Apalutamide: a better option for the treatment of non-metastatic castration resistant prostatic carcinoma”, Int J Basic Clin Pharmacol, vol. 7, no. 9, pp. 1853–1856, Aug. 2018.